Revenue
2017
2018
2019
2020
2021
2022
2023
2024
2025
Sangrix Inc. (SGRX)
Price—Loading quote
Net income
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Free cash flow
2017
2018
2019
2020
2022
2023
Total cash / debt
CashTotal debt
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Financial statements
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | $39,495 | $2.9M | $6.3M | $6.3M | $80.5M | $24.2M | $99.1M | $101.1M | $63.3M |
| Gross profit | N/A | $39,495 | −$945,202 | −$4.6M | −$4.6M | $3.0M | $2.0M | $8.7M | $9.7M | $5.1M |
| Gross margin | N/A | 100.00% | −32.72% | −72.92% | −72.92% | 3.72% | 8.37% | 8.73% | 9.55% | 8.01% |
| Operating expenses | $14.3M | $3.0M | $13.9M | $23.7M | $23.7M | $3.5M | $3.4M | $511,211 | $2.6M | $1.5M |
| Operating income | −$14.3M | −$3.0M | −$14.8M | −$28.3M | −$28.3M | −$3.5M | −$3.4M | −$511,211 | $7.0M | $3.5M |
| Operating margin | N/A | −7,574.87% | −513.62% | −452.07% | −452.07% | −4.32% | −14.20% | −0.52% | 6.97% | 5.57% |
| EBITDA | N/A | −$3.0M | −$13.9M | −$22.9M | −$5.0M | N/A | N/A | $178,323 | $7.6M | $4.1M |
| EBITDA margin | N/A | −7,574.87% | −482.43% | −366.43% | −80.05% | N/A | N/A | 0.18% | 7.50% | 6.41% |
| Net income | −$14.3M | −$4.4M | −$17.5M | −$28.2M | $3.2M | −$45.6M | −$4.9M | $4.4M | $3.8M | $2.5M |
| Net profit margin | N/A | −11,064.45% | −606.95% | −450.66% | 51.74% | −56.66% | −20.11% | 4.40% | 3.73% | 3.88% |
| Basic EPSper basic share | -$70.43 | -$84.84 | -$1,000.00 | -$516.60 | -$2,577.84 | N/A | N/A | $62,874.25 | $56,886.23 | $35,928.14 |
| Diluted EPSper diluted share | -$70.43 | -$84.84 | -$1,000.00 | -$516.60 | -$2,577.84 | N/A | N/A | $62,874.25 | $56,886.23 | $35,928.14 |
Owners
Reported shareholders